I am a child and adolescent psychiatrist committed to improving outcomes for young people who face complex difficulties and systemic barriers. As a clinician, I aim to establish meaningful therapeutic relationships with young people and those supporting them, while also working to advocate for public policy and health systems that improve access to quality mental healthcare.
My main role includes providing inpatient care to older adolescents at the Child Study and Treatment Center through the Behavioral Health Administration, Washington State Department of Social and Health Services, and acting as training lead for psychiatry at this site. My clinical interests include the transition from adolescence to adulthood, the emergence of mood disorder and psychosis, early intervention for personality disorder, and developmental disabilities. I have academic interest in medical education, health service development, and the social determinants of mental health.
I am a psychiatrist at the UW. I primarily work at the Long-Term Civil Commitment Unit at Northwest and the consult service at University of Washington Montlake. I see patients with severe mental illness and chronic mental health problems. I also help with the treatment of patients with delirium and medical comorbidities that impact their mental health. I also help plan and give didactics for the Psychiatry residency at UW. My areas of interests are resident education, consult-liason, global mental health, perinatal psychiatry, and diversity, equity, and inclusion.
Hello! I’m the medical director for the Long Term Civil Commitment Units at the Center for Behavioral Health and Learning. This is a new program as of July 2024 and I am excited to help get it off the ground. I completed my medical school training at the University of Cincinnati, then residency at Oregon Health & Science University, then addiction psychiatry fellowship at UW, then worked at the Puget Sound VA for five years and Providence Swedish for six years prior to starting at UW. I’m thrilled to be part of the team here and looking forward to this next chapter in my career.
I am currently the Medical Director at the Garvey Institute Center for Neuromodulation and am providing leadership to help grow our portfolio in the area of Neuromodulation and Interventional Psychiatry. Before coming to the UW, I was the Muriel Harris Chair of Geriatric Psychiatry and Professor of Clinical Psychiatry at UCLA. While at UCLA, I held many administrative, clinical and teaching leadership positions including serving as Medical Director of Inpatient Geriatric Psychiatry, Chief of Staff of the UCLA Neuropsychiatric Hospital, Founding Faculty of the UCLA Neuromodulation Division, Medical Director of the ECT and Interventional Psychiatry Program, among others.
I recently became Editor-in-Chief of the Journal of ECT and Related Therapies, the official publication of the International Society of ECT and Neurostimulation. My research projects have included investigating various neuromodulation and interventional therapies and developing novel educational programs and curricula. I have an abiding interest in mentoring and helping faculty at the start of their careers and a commitment to fostering the advancement of women and underrepresented minority (URM) faculty in academic medicine.
My work focuses on the development, dissemination, and implementation of tools for the assessment and treatment of autism spectrum disorder. I am also interested in transdiagnostic interventions for autism spectrum disorder to increase efficacy for individuals and families, as well as access to care. My clinical pursuits include conducting diagnostic evaluations for autism for youth of all ages, as well as running groups and classes for autistic individuals and their families.
Sheena Friesen, PhD (she/her), is the attending psychologist for the Child Program on the inpatient Psychiatry and Behavioral Medicine Unit at Seattle Children’s Hospital and Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington. She has clinical expertise in disruptive behavior disorders, comprehensive assessment, Dialectical Behavior Therapy, Exposure Therapies, Parent Training, and Trauma-Focused Cognitive Behavioral Therapy.
Dr. Friesen’s research interests broadly focus on advancing knowledge of least restrictive interventions in acute and complex care contexts, trauma-informed care, and interventions designed to address children’s disruptive behavior problems. She has collaborated on and co-led efforts to design and implement a multi-tiered, Modified Positive Behavioral Interventions and Supports (M-PBIS) model of care aimed at increasing positive behavior interventions, reducing restraint and PRN use, and ameliorating racial gaps in care delivery.
Dr. Friesen received her Ph.D. in School Psychology from the University of Washington in Seattle, WA. She completed her pre-doctoral internship training at Johns Hopkins School of Medicine and Kennedy Krieger Institute and went on to complete her postdoctoral fellowship in acute care and clinical psychology at Seattle Children’s Hospital.
My clinical and research interests center around behavioral and psychological symptoms that present in neurodegenerative diseases, especially dementias. Though dementia is well-known to affect one’s memory and cognition, over 90% of people with dementia develop new neuropsychiatric symptoms – including apathy, dysphoria. anxiety, aggression, agitation, disinhibition, hallucinations, and delusions. Despite the ubiquity of these symptoms, very little is known about how they develop in dementia. My research interests are in understanding more about the molecular and cellular mechanisms of neuropsychiatric symptoms in dementia beyond the well-studied changes associated with cognitive deficits.
Along with my research mentor Martin Darvas PhD (Department of Laboratory Medicine and Pathology), we employ numerous approaches to better understand these neuropsychiatric symptoms, including techniques involving transcriptomic analyses of human and mouse post-mortem tissue, development and implementation of biomarkers derived from human and animal model fluids (plasma, serum, cerebrospinal fluid), virally-mediated gene manipulations, animal modeling of cognitive and neuropsychiatric phenotypes, and basic cellular and molecular biology techniques.
